Pfizer to sell entire Haleon stake
Pfizer will sell its remaining stake in British consumer healthcare group Haleon , the companies said on Tuesday.
Pfizer exits Haleon stake after $3.2B share sale
Pfizer (PFE) stock in focus as the company sells its entire 7.3% stake in Haleon (HLN) for $3.24B. Read more here.
Pfizer Sells Final Haleon Shares for $3.2B, Ends Stake in Consumer Healthcare Giant
Pfizer has finalized the sale of its entire holding in Haleon , generating approximately 2.5 billion ($3.24 billion), Reuters ...
Pfizer (PFE) Bids Farewell to Haleon with $3.3B Final Stake Sale
Pfizer Inc. (PFE) agreed to sell its remaining stake worth $3.3 billion in Haleon PLC (HLN), marking its exit from the UK-based consumer ...
Jim Cramer on Haleon plc (HLN): ‘Stock Has Been Up’
We recently published an article titled Jim Cramer Discusses These 11 Stocks & President Trump’s Tariffs. In this article, we ...
Haleon advances Monday, outperforms market
Haleon PLC closed 6.08% below its 52-week high of £4.18, which the company achieved on March 4th.
Zacks Investment Research on MSN4h
GSK Stock Recovers, Rises Around 17% YTD: Time to Buy, Sell or Hold?
GSK GSK stock has risen 16.9% year to date compared with an increase of 7.0% for the industry. The stock has also ...
Morningstar13d
Haleon PLC ADR HLN
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Pfizer Set to Raise $3.3 Billion in Final Haleon Stake Sale
Pfizer Inc. is offering about 662 million shares in Haleon Plc, representing its remaining stake in the maker of Sensodyne ...